Drug-induced Parkinson`s disease. A clinical review

Neurosciences (Riyadh). 2013 Jul;18(3):215-21.

Abstract

Drug-induced Parkinsonism must always be suspected when parkinsonian symptom like rigidity, tremor, or postural instability appear in patients receiving drug treatment. Indeed, drug-induced Parkinsonism is a frequent etiology of secondary Parkinsonism. The main causative drugs are antipsychotic, other neuroleptic drugs, and calcium-channel entry blockers. The risk associated with antipsychotics is often dose dependent and related to dopamine D2 striatal occupancy. The risk is less for the second-generation atypical antipsychotic. The other treatments rarely involved are antidepressants, antivirals, anti-arrhythmics, lithium, valproic acid, and others. Regression of symptom will be observed in most cases after a mean delay of 3 months after cessation of treatment. In one-tenth of cases, symptoms persist after drug withdrawal leading to the diagnosis of underlined idiopathic Parkinson`s disease.

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects*
  • Antidepressive Agents / adverse effects*
  • Antipsychotic Agents / adverse effects*
  • Humans
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / diagnosis
  • Parkinson Disease, Secondary / drug therapy

Substances

  • Anti-Arrhythmia Agents
  • Antidepressive Agents
  • Antipsychotic Agents